Retinopathy of prematurity (ROP) is a retinal vasoproliferative disease that affects premature
infants. Despite improvements in neonatal care and management guidelines, ROP remains …

Abstract Development of the retinal vasculature is based on highly coordinated signalling
between different cell types of the retina, integrating internal metabolic requirements with …

1. Methods Literature search timeframe: The references cited in the previous guidelines [1]
are not repeated here, except for some relevant publications, and only the previous …

Importance Lack of arachidonic acid (AA) and docosahexaenoic acid (DHA) after extremely
preterm birth may contribute to preterm morbidity, including retinopathy of prematurity (ROP) …

The incidence of retinopathy of prematurity (ROP) continues to rise due to the improved
survival of very low birth weight infants in developed countries. This epidemic is also fueled …

NASH is becoming increasingly common worldwide because of the growing global
prevalence of obesity and consequently NAFLD. Unfortunately, the mechanism of …

Retinopathy of prematurity (ROP) is a vasoproliferative disorder of the retina and a leading
cause of visual impairment and childhood blindness worldwide. The disease is …

Ischemic retinopathies (IRs), such as retinopathy of prematurity (ROP), diabetic retinopathy
(DR), and (in many cases) age‐related macular degeneration (AMD), are ocular disorders …

This article summarizes the presentations given at an ESPEN Workshop on “Lipids in the
ICU” held in Tel Aviv, Israel in November 2014 and subsequent discussions and updates …

Background & aims The purpose of the study was to compare the effects of the parenteral
emulsion SMOFlipid®, with 15% fish oil, with Clinoleic® on retinopathy of prematurity (ROP) …